eppen_Himac_Jan1_2022
  Editorial
 A GOOD PROPOSAL BY DOP   
 Wednesday, January 19, 2022 
 The Department of Pharmaceuticals (DoP) has recently come out with a proposal to design a Bayh-Dole Act (BDA) like policy of the US to encourage academicians to set up independent companies (spin offs) to move academic discoveries into the commercial landscape 
  Past Editorial...  
Thermo_Fisher_Nov2021
TODAY'S NEWS
18:00  [IST]Oncolytics Biotech provides enrollment update on multi-indication phase 1/2 gastrointestinal cancer trial at 2022 ASCO-GI symposium
17:00  [IST]NIH awards $170 million for precision nutrition study
16:00  [IST]Regulus completes Pre-IND meeting with US FDA for RGLS8429
15:00  [IST]US FDA releases CDRH Health of Women Strategic Plan to better inform medical device research and regulation for all women
14:00  [IST]Pfizer, Opko’s Ngenla to treat paediatric growth hormone deficiency receives Japanese approval
13:00  [IST]US EPA & WHO sign five-year MoU to protect public health
more news >>
TOP NEWS
08:00  [IST]Pharmexcil seeks inputs from members on need for continuation of EPCG scheme
08:00  [IST]MedTech industry expects Union budget to address issues like health cess, reduction of custom duties
08:00  [IST]Govt of NCT of Delhi changes nomenclature of senior pharmacists in service to pharmacy officers
08:00  [IST]AI, robotics & nanotechnology to reshape future of Indian healthcare: Satyaki Banerjee
08:00  [IST]Pharma industry files investment intentions of Rs. 12,655 crore in first 11 months of 2021
08:00  [IST]Centre mandates QR code on labels of all APIs manufactured and imported from January 2023
more news >>
biopol
YESTERDAY'S NEWS
16:50  [IST]Bajaj Group and L V Prasad Eye Institute partner to eliminate retinal blindness
16:30  [IST]AiMeD urges finance minister to increase custom duty, health cess
15:45  [IST]IHL Care launches digital health centre
15:20  [IST]Vestige launches Melatonin oral spray to improve sleep cycle
15:10  [IST]Fermenta Biotech licenses its proprietary enzymatic technology for manufacturing molnupiravir to Aurigene Pharma
14:50  [IST]Biophore receives sub-license from MPP to manufacture and market molnupiravir for Covid treatment
more news >>
INTERVIEW  
Pharmexcil to explore export promotion opportunities for pharma exporters by holding B2B and BSM meets
S_V_Veerramani.jpgS V Veeramani, president of Indian Drug Manufacturers’ Association (IDMA)
Past Interviews...
 
  What's New?  
 
Opinion Poll
 
 
Will the new D Pharm syllabus published by PCI adequate to create next-gen pharmacists?
 
 
 
   
 
  Corporate
Pharma Stocks
Executive Diary
Pharma People
Product Launches
  Special Features
Features
  Chronicle Pharmabiz Specials
Forthcoming
  Past
 
  Forthcoming Events
International
  Domestic
 
TENDERS & PROJECTS
Tenders & Enquiries
Pharma Projects
CORPORATE
Company Profile
Corporate Results
Corporate X-ray
Pharmabiz Studies of Top Companies
US FDA UPDATE
US FDA: ANDA
US FDA: Warnings
US FDA: Approved NMEs
US FDA: New Approvals
EXPORT & IMPORT
Drug Export Procedures
Drug Units With WHO GMP Certification
Pharma Export Data
Import Reg. Update
PHARMA LAWS & DOCUMENTS
Notifications
Pharma Regulations
Patent Laws and Amendments
Patent Scan
Documents
New Drug Approvals
Notified Prices
LIST OF LABS & GOVT. BODIES
Govt Recognised In-House R&D Units
AICTE Boards & Committees
List of Indian CROs
List of CROs (International)
Govt & approved labs of India
List of State Drugs Controllers
 
 
 
 
Copyright © 2016 Saffron Media Pvt. Ltd |